Evofem Biosciences, Inc. Common Stock
EVFM
EVFM was delisted on the 10th of August, 2022.
14 hedge funds and large institutions have $287K invested in Evofem Biosciences, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
7% less funds holding
Funds holding: 15 → 14 (-1)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
84% less capital invested
Capital invested by funds: $1.8M → $287K (-$1.51M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
+$21.1K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$623 |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$623 |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$208 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$19K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.98K |
| 4 |
Goldman Sachs
New York
|
-$1.35K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.04K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
UBS AM
Chicago,
Illinois
| $105K | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $81K | -$1.04K | -10 | -1% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $40K | +$208 | +2 | +0.5% |
|
|
ARTA
4
A.R.T. Advisors
New York
| $20K | +$21.1K | +203 | New |
|
|
5
Goldman Sachs
New York
| $18K | -$1.35K | -13 | -7% |
|
6
Morgan Stanley
New York
| $7K | – | – | – |
|
|
BIT
7
BlackRock Institutional Trust
San Francisco,
California
| $6K | – | – | – |
|
|
WAS
8
WESPAC Advisors SoCal
Pasadena,
California
| $3.36K | – | – | – |
|
|
9
UBS Group
Zurich,
Switzerland
| $2K | -$4.98K | -48 | -69% |
|
|
BA
10
BlackRock Advisors
Wilmington,
Delaware
| $2K | – | – | – |
|
|
BFA
11
BlackRock Fund Advisors
San Francisco,
California
| $2K | +$623 | +6 | +46% |
|
|
LTFS
12
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | +$623 | +6 | New |
|
|
VKH
13
Virtu KCG Holdings
New York
| – | -$19K | -190 | Closed |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$17K | -164 | Closed |
|
EVFM Hedge Fund Activity: Q4 2016 in Review
14 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Evofem Biosciences, Inc. Common Stock (EVFM) for Q4 2016, worth a combined $287K — down 84% from $1.8M a quarter earlier.
Fund positioning in EVFM was balanced in Q4 2016: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was A.R.T. Advisors, opening a new position worth an estimated $21.1K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $19K sold.
- 14 institutional investors held Evofem Biosciences, Inc. Common Stock (EVFM) as of Q4 2016, down from 15 in Q3 2016.
- Funds reported $287K of Evofem Biosciences, Inc. Common Stock stock for Q4 2016, down 84% quarter-over-quarter.
- 2 funds opened new Evofem Biosciences, Inc. Common Stock positions in Q4 2016 and 2 closed out, a net change of 0 holders.
- The largest Evofem Biosciences, Inc. Common Stock buyer in Q4 2016 was A.R.T. Advisors, an estimated $21.1K added.
- The largest Evofem Biosciences, Inc. Common Stock seller in Q4 2016 was Virtu KCG Holdings, an estimated $19K sold.
Based on aggregated 13F filings for Q4 2016.